Journal article
The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis
YH Sheng, R Lourie, SK Lindén, PL Jeffery, D Roche, TV Tran, CW Png, N Waterhouse, P Sutton, THJ Florin, MA McGuckin
Gut | BMJ PUBLISHING GROUP | Published : 2011
Abstract
Background and Aims: The MUC13 transmembrane mucin is highly and constitutively expressed in the small and large intestine. Although MUC13 polymorphisms have been associated with human inflammatory bowel diseases and susceptibility to Escherichia coli infection in pigs, the biological functions of MUC13 are unknown. This study aimed to explore whether MUC13 modulates intestinal inflammation. Methods: Muc13 -/- mice were generated, phenotyped and challenged with the colitis-inducing agent, dextran sodium sulphate (DSS). Colitis was assessed by clinical symptoms and intestinal histopathology. Intestinal epithelial cell apoptosis and proliferation, macrophage infiltration and cytokine productio..
View full abstractRelated Projects (1)
Grants
Awarded by NHMRC
Funding Acknowledgements
Supported by NHMRC project grant 543704, MAM is supported by a NHMRC Senior Research Fellowship, THJF is supported by a NHMRC Practitioner Fellowship. SKL is supported by the Swedish Research Council (Vetenskapsradet), PLJ is supported by a Queensland Government Smart Futures Fellowship.